NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Mayela Mendt
M D Anderson Cancer Center University of Texas - Houston / United States
Others
AD Scientific Index ID: 1417448
MD Anderson Cancer Center
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mayela Mendt's MOST POPULAR ARTICLES
1-)
Generation and testing of clinical-grade exosomes for pancreatic cancerM Mendt, S Kamerkar, H Sugimoto, KM McAndrews, CC Wu, M Gagea, ...JCI insight 3 (8), 20184372018
2-)
Mesenchymal stem cell-derived exosomes for clinical useM Mendt, K Rezvani, E ShpallBone marrow transplantation 54 (2), 789-792, 20192482019
3-)
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsM Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ...Blood 137 (5), 624-636, 20211012021
4-)
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cellsH Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ...The Journal of clinical investigation 131 (14), 20211892021
5-)
Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood–derived NK cells facilitates CAR-like responses against CD30+ malignanciesLN Kerbauy, ND Marin, M Kaplan, PP Banerjee, MM Berrien-Elliott, ...Clinical Cancer Research 27 (13), 3744-3756, 20211202021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept